Tetralogic Pharmaceuticals Corp Coverage Initiated at Needham & Company (TLOG)
Stock analysts at Needham & Company initiated coverage on shares of Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) in a report issued on Monday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
Shares of Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) traded up 1.82% during mid-day trading on Monday, hitting $10.6703. The stock had a trading volume of 68,591 shares. Tetralogic Pharmaceuticals Corp has a one year low of $6.91 and a one year high of $10.97. The stock’s 50-day moving average is $8.1 and its 200-day moving average is $8.1. The company’s market cap is $137.6 million.
Separately, analysts at Guggenheim initiated coverage on shares of Tetralogic Pharmaceuticals Corp in a research note to investors on Monday. They set a “buy” rating and a $15.00 price target on the stock.
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) is a clinical-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.